Your bridge to patients
in emerging markets
Unique solutions for
rare diseases
Promoting access to
life-saving medicines
Mastering orphan
drug pathways
Transforming
patient outcomes
Expanding
healthcare access
Commitment to
global health
We are a member of
Specializing in
rare diseases
We focus on rare disease offering extensive expertise in commercialization of orphan and ultra orphan products. Our mission is to promote healthcare equality by helping leading pharmaceutical companies to provide life-saving therapies to underserved markets.
Covering a wide geographical area
Our capabilities include helping you expand into over 30 emerging markets, creating value for your company, addressing unmet patient needs, and managing risks effectively to ensure a competitive and swift financial return.
Providing a full scope of services
Our team
With over 20 years of experience in large pharma and direct market expertise, our team is dedicated to delivering life-changing medicines to patients in our operational countries.
Partner with Biomedica and commit to a healthier and more equitable world
Explore our latest news and insights
Read hereOur testimonials
Prof. Oleg Kvlividze
MD, PhD
- Georgian Foundation for Genetic and Rare Diseases (GeRaD) - CEO
- EURORDIS, Full Member
- RDI, Full Member
- IRDIRC, FCC Member
Halyna Kurylo
PhD, Pediatric Surgeon
- Head of Surgery Department of Lviv City Clinical Children Hospital
Dr. Dair Nurgaliev
MD, PhD
- Head of Oncology & Bone Marrow Transplantation Department, “University Medical Center” Corporate Fund, Astana, Kazahstan
Prof. Oleg Kvlividze
MD, PhD
- Georgian Foundation for Genetic and Rare Diseases (GeRaD) - CEO
- EURORDIS, Full Member
- RDI, Full Member
- IRDIRC, FCC Member
Halyna Kurylo
PhD, Pediatric Surgeon
- Head of Surgery Department of Lviv City Clinical Children Hospital
Dr. Dair Nurgaliev
MD, PhD
- Head of Oncology & Bone Marrow Transplantation Department, “University Medical Center” Corporate Fund, Astana, Kazahstan
Looking for a strategic guidance?
Reach out to our team for market assessment specific to your product and understand the financial impact you can achieve by partnering with us.